Dr Camille Guillerey

Translational Research Institute 

Camille has already contributed to research that demonstrates that ‘killer’ immune cells can slow the growth of blood cancers, and that the functioning of these cells can be stimulated by certain immunotherapy drugs. She is studying how to better educate these ‘killer’ cells through vaccination research, so they can recognise and eliminate cancer cells.

“The work should help us design better treatments”.

Blood cancers are a major health problem with around 12,000 new cases expected in Australia this year.